Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia

Biomimetic doxorubicin/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) showed limited clinical therapeutic efficiency with chemotherapy for its multi-distributed lesions and hard-to-kill leukemia cells deep in the bone marrow. Results Here, a biomimetic nanosystem (DR@PLip) based on platelet membrane (PM) coating and dox...

Full description

Bibliographic Details
Main Authors: Mo Chen, Yingyu Qiao, Jie Cao, La Ta, Tianyuan Ci, Xue Ke
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Journal of Nanobiotechnology
Subjects:
Acute myeloid leukemia
Chemoimmunotherapy
Ginsenoside
Leukemia cells targeting
Online Access:https://doi.org/10.1186/s12951-022-01491-w

Internet

https://doi.org/10.1186/s12951-022-01491-w

Similar Items